Blood samples from recipients of both doses of Sputnik showed that the vaccine was 6 times less effective against the Beta variant in laboratory tests.
Swaminathan warned that it will be a chaotic situation in countries if citizens start deciding ‘when and who should be taking a second, third or fourth dose’.
The first batch produced at Panacea Biotec's facilities in Himachal Pradesh will be shipped to Russia for quality control. Full-scale production is expected to start this summer.
Earlier Deputy Chief Minister Manish Sisodia claimed that Covaxin manufacturer Bharat Biotech has refused to provide additional doses to the national capital.
The imported doses of the Covid vaccine, which received regulatory clearance on 13 May, are presently priced at a maximum retail price of Rs 948, with 5% GST per dose.
Not many are taking the Sputnik V vaccine with the low numbers being blamed on Russians’ distrust of officialdom dating back to the Soviet era and doubts over the vaccine.
Pakistan has already ordered 1.2 million doses of Chinese Sinopharm vaccine, with deliveries to start 31 January. It has also given approval to AstraZeneca shot for private use.
No safety concerns identified during Sputnik V mid-stage trial, data has been submitted to Drugs Controller General of India for a review, Dr. Reddy’s says in a statement.
Russia hasn’t released late-stage phase 3 data on its vaccine. That said, what we do know about Sputnik V and its design should give us some degree of confidence.
The reasons for both sides preventing any escalation lie in the political and military context of the strategic situation in West Asia within the larger global geopolitical framework.
Economists say there are weaknesses in India’s GDP data. But statisticians claim the accusations are based on flawed understanding, saying while GDP has problems, the economists are looking in the wrong places.
Coaching centres for Army aspirants in Jhunjhunu are shutting down due to plummeting admissions in the face of a lack of job guarantees under Agnipath Scheme.
COMMENTS